Searched for
PHARMEASY FUNDING
Nandan Nilekani's Fundamentum bets big on AI, deeptech with Rs 3,000 crore purseFundamentum Partnership has launched F2A, a Rs 3,000 crore frontier-tech investment platform focused on AI and deeptech startups. The firm ...
FirstCry, Slice’s FY26 numbers; Nilekani’s Fundamentum eyes deeptech pushFirstCry parent cut its losses in the March quarter on tightened costs. This and more in today's ETtech Top 5.
Mother's Day Special: How AI, apps are empowering women to manage finances, improve health, build careerWomen are learning to keep pace with the ubiquitous apps and AI, shrugging off dependence on their kids for financial transactions, online ...
Pharmacy startup Plazza in talks to raise $12-15 million from Accel, Nexus, ElevationPlazza, a quick medicine delivery startup, is in talks to secure $12-15 million in funding. This new capital will help Plazza expand its ph...
Goldman may convert part-debt into equity in PharmEasyThe online pharmacy is also in talks to restructure debt terms ahead of rights issue; share sale set to open on September 4
US investor Janus Henderson cuts PharmEasy valuation by half to $2.8 billionThe global investor, which picked a stake in PharmEasy in September 2021, has reduced the valuation of its holding in the firm by half, whi...
Exclusive | Not selling Thyrocare, will cut cash burn: PharmEasy founders to boardPharmEasy’s parent API Holdings has also delayed internal plans for a potential initial public offering (IPO) to 2025, the people privy to ...
PharmEasy prepares Rs 750 crore funding through convertible notesProsus Ventures, Temasek and others participate; online pharmacy reconsidering external fundraise amid funding slowdown
PharmEasy in talks to raise upto $300 million, valuation may drop by halfExisting investors will also put in $70 million, valuation at $2.5-$2.75 versus $5.4 billion of last year’s pre-IPO round. IPO is shelved f...
PharmEasy plans $200 million fund raising at lower valuationPharmEasy's planned fund raising is set to see participation from some existing investors, who have indicated they will commit about $115 m...
PharmEasy parent API Holdings files papers for Rs 6,250 crore IPOAPI Holdings, the parent of online pharmacy PharmEasy, has filed its draft red herring prospectus (DRHP) with market regulator Sebi for a ₹...
PharmEasy parent to file DRHP soon for Rs 6,000-7,000 crore IPOThe IPO of PharmEasy’s parent API Holdings is expected to be a fully primary share sale. The e-pharmacy — India’s largest — aims to list be...
PharmEasy closes pre-IPO funding round at $5.6 billion valuationPharmEasy founders — Siddharth Shah, Dhaval Shah, Dhramil Sheth, Harsh Parekh and Hardik Dedhia — have received new stock options ahead of ...
Ecomm sales boom in festive season; PharmEasy raises $350 millionFrom refrigerators to clothes, ecommerce firms accounted for a higher share of total sales than they did this time last year. Read on to fi...
Exclusive: New investors in talks to join PharmEasy’s pre-IPO funding roundThe company has also finalised a secondary transaction of around $100 million in which some existing investors, such as Infosys cofounder N...
Pre-IPO bout to value PharmEasy at $6 billionTalks on with Amansa, Blackstone, OrbiMed and others as e-pharmacy eyes IPO at $7-8 billion valuation.
Pharmeasy in funding talks with SoftBank after Thyrocare dealPharmeasy’s parent API Holdings is seeking a valuation of at least $5.6 billion in a new funding round. SoftBank could invest $150 million ...
ETtech Exclusive: PharmEasy gets $300 million booster shot for Thyrocare dealPharmEasy has raised $300 million more, bringing the total funding received by the online pharmacy since April to $650 million, most of whi...
- Pharmeasy to make acquisitions post $50 million funding
Pharmeasy has been valued at $150 million post the round, as per sources. Existing investors BVP also participated in this round.
Pharmacy aggregator Pharmeasy raises venture debt from Trifecta CapitalMore than 100 chemists are registered with Pharmeasy and have seen as much as six-fold increase in their business since they enrolled.